CareDx, Inc. · 1 day ago
Revenue Cycle Analyst
United States
Full-time
Remote
Entry, Mid Level
$76K/yr - $95K/yr
2+ years expCareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of healthcare solutions for transplant patients. The Revenue Cycle Analyst will analyze payer denial trends, perform root cause analysis, and report on key performance indicators to enhance reimbursement processes.
BiotechnologyHealth CareHealth DiagnosticsInformation Technology
Responsibilities
Perform root cause analysis to identify trends related to denials and rejections, authorization outcomes, and reimbursement issues. Develop a data-driven plan to partner with management in executing reimbursement resolution strategies
Produce monthly KPIs and required month end reporting. Identify payers and reasons for changes
Proactively identify reimbursement opportunities
Accurately produce and analyze ad-hoc data requests to stakeholders and management within Revenue Cycle – Billing and Authorization functions, Finance, and Market Access
Confidently identify bottlenecks within the reimbursement process to reduce DSO, decrease accounts receivable, improve success of appeals and records, and increase collections
Assist management and team with tracking action plans to ensure timely collections and timely follow up
Creatively utilize dashboards via established platforms (Tableau/SQL/PowerBI) and advanced excel to visually represent data and statistically determine reimbursement expectations and effectively communicate improvement suggestions to stakeholders
Develop dashboards and standardized reporting utilizing data tools which could include, but not limited to: Payer score cards, work queue prioritization and reporting, A/R and adjustment research, bulk collection dashboards, and system maintenance
Identify gaps and areas of improvement in analytics capabilities and work with technical teams and Business Intelligence Analyst to implement enhancements that improve denial and reimbursement issues identification
Assist with PAMA reporting for all required tests and other state required reporting functions with accuracy and timely delivery
Develop a thorough understanding of systems, processes and payer-specific reimbursement processes and billing requirements, assisting in the proactive identifications of opportunities for Revenue Cycle improvement
Qualification
Required
Bachelor's degree in quantitative field required
Advanced knowledge of Microsoft Excel and experience with data tools (SQL, Tableau, Power BI, Looker)
2+ years of experience in Revenue Cycle, Billing or related experience required
Working knowledge of ICD-10, CPT, and HCPCS coding, DSO reductions, accounts receivable, HIPPA, authorization process, and contracting
Ability to prioritize and manage multiple concurrent tasks
A collaborative and proactive problem-solver with exceptional communication and interpersonal skills with excellent time management
Benefits
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
Company
CareDx, Inc.
CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
501-1000 employees
H1B Sponsorship
CareDx, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (8)
2023 (4)
2022 (22)
2021 (21)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$574.89MKey Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M
Leadership Team
John Hanna
President and CEO
Nathan Smith
Chief Financial Officer
Recent News
2026-01-16
2026-01-14
Company data provided by crunchbase